human red blood cells treated with the cuzn superoxide dismutase inhibitor diethyldithiocarbamate ( ddc ) undergo metabolic modifications in addition to the superoxide dismutase inhibition : oxidation of the reduced glutathione ( gsh ) to oxidized glutathione ( gssg ) , methemoglobin formation , and increased hexose monophosphate shunt activity were observed .
C0086418
human
C0010461
cuzn superoxide dismutase